THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT

DEFINITIVE CONTRACT won by KALEO, INC. · work in GLEN ALLEN, VA
$96,058,494
RecipientKALEO, INC. UEI LBM4GLJNDK31
Award ID75A50126C00010
Award amount$96,058,494
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN11
Set-asideUnrestricted
Start dateSep 30, 2026
End dateDec 31, 2034
Place of performanceGLEN ALLEN, VA
Record updatedSep 28, 2026

View the official award record

More awards won by KALEO, INC.

DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE
Department of Health and Human Services · $33,258,615 · Apr 11, 2024

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids